Toshihiro Shiozawa (Hiroaki Satoh, Haruka Namikawa, Katsunori Kagohashi)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

The clinical respiratory journal

Advances in respiratory medicine

Thoracic cancer

The Eurasian journal of medicine

University of Tsukuba

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tsukuba

Japan

Professor

Publications

Ou Yamaguchi, Keita Mori, Saori Takata, Kazuhiko Shibata, Kenichi Chikamori, Nozomu Kimura, Yoshiaki Nagai, Taku Nakagawa, Satoshi Igawa, Taishi Harada, Hiroshige Yoshioka, Hisashi Tanaka, Hitomi Nogawa, Toshihiro Shiozawa, Toshihiro Shiozawa, Kosuke Tsuji, Kunihiko Kobayashi, Kyoichi Kaira
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study). Thoracic cancer (2023)
Akimasa Sekine, Goushi Matama, Eri Hagiwara, Erina Tabata, Satoshi Ikeda, Tsuneyuki Oda, Ryo Okuda, Hideya Kitamura, Tomohisa Baba, Toshihiro Shiozawa, Toshihiro Misumi, Shigeru Komatsu, Tae Iwasawa, Takashi Ogura
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy. Thoracic cancer 13 (17) (2022)
Kengo Nishino, Yuika Sasatani, Gen Ohara, Toshihiro Shiozawa, Hiroaki Satoh
Nintedanib-mediated improvement in CT imaging in pulmonary fibrosis associated with systemic scleroderma. Advances in respiratory medicine 89 (5) (2021)
Toshihiro Shiozawa, Kunihiko Miyazaki, Toshihiro Shiozawa, Katsunori Kagohashi
Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2021)
Shotaro Ono, Toshihiro Shiozawa, Hideji Nakajima, Katsunori Kagohashi, Hiroaki Satoh, Kinya Furukawa
A tracheobronchial adenoid cystic carcinoma incidentally detected by chest radiography and pulmonary function test. Advances in respiratory medicine 89 (3) (2021)
Katsunori Kagohashi, Kunihiko Miyazaki, Toshihiro Shiozawa, Hiroaki Satoh
Pseudoprogression during successful rechallenge of immune checkpoint inhibitor in a NSCLC patient. Advances in respiratory medicine 89 (3) (2021)
Satoshi Kamoshida, Shinichiro Okauchi, Hajime Osawa, Gen Ohara, Katsunori Kagohashi, Toshihiro Shiozawa
Effect of Shakuyakukanzoto on Chemotherapy-Induced Hiccups in Patients with Lung Cancer. The Eurasian journal of medicine 53 (1) (2021)
Shinichiro Okauchi, Kunihiko Miyazaki, Hideyasu Yamada, Toshihiro Shiozawa
Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor. The clinical respiratory journal 14 (5) (2020)
Shinichiro Okauchi, Katsunori Kagohashi, Toshihiro Shiozawa, Kunihiko Miyazaki, Toshihiro Shiozawa
Early pleural effusion control in patients with lung cancer. Respirology (Carlton, Vic.) 25 (11) (2020)
Yuika Sasatani, Shinichiro Okauchi, Gen Ohara, Katsunori Kagohashi, Toshihiro Shiozawa
Prolonged response after the discontinuation of nivolumab after resistance to gefitinib. The clinical respiratory journal 13 (10) (2019)
Hideyasu Yamada, Toshihiro Shiozawa, Norihito Hida, Taisuke Nakaizumi, Hideo Terashima, Nobuyuki Hizawa
Osimertinib for an older de novo T790M patient with chronic kidney disease. Geriatrics & gerontology international 18 (3) (2019)
Tomohiro Tamura, Katsunori Kagohashi, Toshihiro Shiozawa
Lung cancer in patients with combined pulmonary fibrosis and emphysema. The clinical respiratory journal 12 (3) (2017)
Tomohiro Tamura, Toshihiro Shiozawa
Psychological condition of patients with asthma. The clinical respiratory journal 12 (4) (2017)

Toshihiro Shiozawa.css-eqlu8i{font-size:small;padding-left:4px;} (Hiroaki Satoh, Haruka Namikawa, Katsunori Kagohashi)

Publication Activity (10 Years)

Top Topics

Top Venues

Toshihiro Shiozawa (Hiroaki Satoh, Haruka Namikawa, Katsunori Kagohashi)